Entos Pharmaceuticals Announces Launch of US-Based Spinout Company Aegis Life, Inc. to Support its Global Vaccine Commercialization Strategy

SourceOA online
Date Published10/15/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Aegis Life, Inc.
Parent companyEntos Pharmaceuticals
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:Both
Country(ies) from which reshored:Canada
City reshored to:San Diego
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshorednovel DNA vaccines, Covid-19 vaccine, vaccines
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Skilled workforce availability/training, Other, Covid-19
Find Reshoring Articles